Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge

β-tryptases are responsible for most of the proteolytic activity during mast cell activation. Here, the authors develop β-tryptase-inhibiting antibodies and provide structural and biochemical evidence that the bivalency of the antibodies is a prerequisite for their inhibitory activity.

Guardado en:
Detalles Bibliográficos
Autores principales: Henry R. Maun, Rajesh Vij, Benjamin T. Walters, Ashley Morando, Janet K. Jackman, Ping Wu, Alberto Estevez, Xiaocheng Chen, Yvonne Franke, Michael T. Lipari, Mark S. Dennis, Daniel Kirchhofer, Claudio Ciferri, Kelly M. Loyet, Tangsheng Yi, Charles Eigenbrot, Robert A. Lazarus, James T. Koerber
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/731be2a1b0e94f0d9e6e6bb1c65b39da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:731be2a1b0e94f0d9e6e6bb1c65b39da
record_format dspace
spelling oai:doaj.org-article:731be2a1b0e94f0d9e6e6bb1c65b39da2021-12-02T10:48:19ZBivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge10.1038/s41467-020-20143-x2041-1723https://doaj.org/article/731be2a1b0e94f0d9e6e6bb1c65b39da2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-20143-xhttps://doaj.org/toc/2041-1723β-tryptases are responsible for most of the proteolytic activity during mast cell activation. Here, the authors develop β-tryptase-inhibiting antibodies and provide structural and biochemical evidence that the bivalency of the antibodies is a prerequisite for their inhibitory activity.Henry R. MaunRajesh VijBenjamin T. WaltersAshley MorandoJanet K. JackmanPing WuAlberto EstevezXiaocheng ChenYvonne FrankeMichael T. LipariMark S. DennisDaniel KirchhoferClaudio CiferriKelly M. LoyetTangsheng YiCharles EigenbrotRobert A. LazarusJames T. KoerberNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Henry R. Maun
Rajesh Vij
Benjamin T. Walters
Ashley Morando
Janet K. Jackman
Ping Wu
Alberto Estevez
Xiaocheng Chen
Yvonne Franke
Michael T. Lipari
Mark S. Dennis
Daniel Kirchhofer
Claudio Ciferri
Kelly M. Loyet
Tangsheng Yi
Charles Eigenbrot
Robert A. Lazarus
James T. Koerber
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
description β-tryptases are responsible for most of the proteolytic activity during mast cell activation. Here, the authors develop β-tryptase-inhibiting antibodies and provide structural and biochemical evidence that the bivalency of the antibodies is a prerequisite for their inhibitory activity.
format article
author Henry R. Maun
Rajesh Vij
Benjamin T. Walters
Ashley Morando
Janet K. Jackman
Ping Wu
Alberto Estevez
Xiaocheng Chen
Yvonne Franke
Michael T. Lipari
Mark S. Dennis
Daniel Kirchhofer
Claudio Ciferri
Kelly M. Loyet
Tangsheng Yi
Charles Eigenbrot
Robert A. Lazarus
James T. Koerber
author_facet Henry R. Maun
Rajesh Vij
Benjamin T. Walters
Ashley Morando
Janet K. Jackman
Ping Wu
Alberto Estevez
Xiaocheng Chen
Yvonne Franke
Michael T. Lipari
Mark S. Dennis
Daniel Kirchhofer
Claudio Ciferri
Kelly M. Loyet
Tangsheng Yi
Charles Eigenbrot
Robert A. Lazarus
James T. Koerber
author_sort Henry R. Maun
title Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
title_short Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
title_full Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
title_fullStr Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
title_full_unstemmed Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
title_sort bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the igg hinge
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/731be2a1b0e94f0d9e6e6bb1c65b39da
work_keys_str_mv AT henryrmaun bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT rajeshvij bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT benjamintwalters bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT ashleymorando bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT janetkjackman bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT pingwu bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT albertoestevez bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT xiaochengchen bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT yvonnefranke bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT michaeltlipari bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT marksdennis bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT danielkirchhofer bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT claudiociferri bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT kellymloyet bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT tangshengyi bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT charleseigenbrot bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT robertalazarus bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
AT jamestkoerber bivalentantibodypliersinhibitbtryptasebyanallostericmechanismdependentontheigghinge
_version_ 1718396655266430976